Literature DB >> 27908353

The Risk Continuum of Atherosclerosis and its Implications for Defining CHD by Coronary Angiography.

Armin Arbab-Zadeh1, Valentin Fuster2.   

Abstract

Patients undergoing coronary angiography for suspected coronary heart disease who are found to have coronary atherosclerotic disease with <50% diameter stenosis may carry a risk of adverse cardiac events similar to that in patients with single-vessel obstructive disease. Yet clinical practice guidelines offer no direction for managing symptomatic patients with nonobstructive coronary atherosclerosis because current diagnostic criteria for coronary heart disease are not met. Accordingly, secondary preventive measures are not endorsed, and their role is not defined in this setting. Available data suggest that we are missing the opportunity to provide effective preventive measures in millions of patients with nonobstructive coronary heart disease. The emergence of noninvasive coronary angiography in patients with suspected coronary heart disease provides the opportunity to transition from a categorical perspective on the presence or absence of coronary heart disease to accepting the risk continuum from atherosclerosis and its implications for diagnosis and management.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atherosclerotic plaque; coronary artery disease; ischemic heart disease

Mesh:

Year:  2016        PMID: 27908353     DOI: 10.1016/j.jacc.2016.08.069

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  28 in total

1.  Invasive coronary angiography findings across the CAD-RADS classification spectrum.

Authors:  Gaston A Rodriguez-Granillo; Patricia Carrascosa; Alejandro Goldsmit; Armin Arbab-Zadeh
Journal:  Int J Cardiovasc Imaging       Date:  2019-06-21       Impact factor: 2.357

Review 2.  CT as gatekeeper of invasive coronary angiography in patients with suspected CAD.

Authors:  Carlos A G Van Mieghem
Journal:  Cardiovasc Diagn Ther       Date:  2017-04

Review 3.  Aggressive lipid-lowering therapy after percutaneous coronary intervention - for whom and how?: Aggressive lipid-lowering therapy after PCI.

Authors:  Zhen-Vin Lee; Ho Lam
Journal:  AsiaIntervention       Date:  2022-03-15

4.  Analysis of Risk Factors of Coronary Heart Disease and Its Correlation with Inflammatory Factors in Patients with Type 2 Diabetes Mellitus.

Authors:  Zhigang Wang; Hui Zhao; Qian Zhou
Journal:  Biomed Res Int       Date:  2022-06-24       Impact factor: 3.246

Review 5.  Evaluation of coronary stenosis versus plaque burden for atherosclerotic cardiovascular disease risk assessment and management.

Authors:  Omar Dzaye; Alexander C Razavi; Michael J Blaha; Martin Bødtker Mortensen
Journal:  Curr Opin Cardiol       Date:  2021-11-01       Impact factor: 2.108

6.  Prognostic value of noninvasive combined anatomic/functional assessment by cardiac CT in patients with suspected coronary artery disease - Comparison with invasive coronary angiography and nuclear myocardial perfusion imaging for the five-year-follow up of the CORE320 multicenter study.

Authors:  Marc Dewey; Carlos E Rochitte; Mohammad R Ostovaneh; Marcus Y Chen; Richard T George; Hiroyuki Niinuma; Kakuya Kitagawa; Roger Laham; Klaus Kofoed; Cesar Nomura; Hajime Sakuma; Kunihiro Yoshioka; Vishal C Mehra; Masahiro Jinzaki; Sachio Kuribayashi; Michael Laule; Narinder Paul; Arthur J Scholte; Rodrigo Cerci; John Hoe; Swee Yaw Tan; Frank J Rybicki; Matthew B Matheson; Andrea L Vavere; Andrew E Arai; Julie M Miller; Christopher Cox; Jeffrey Brinker; Melvin E Clouse; Marcelo Di Carli; João A C Lima; Armin Arbab-Zadeh
Journal:  J Cardiovasc Comput Tomogr       Date:  2021-05-12

7.  Accuracy of non-invasive stress testing in women and men with angina in the absence of obstructive coronary artery disease.

Authors:  Vedant S Pargaonkar; Yuhei Kobayashi; Takumi Kimura; Ingela Schnittger; Eric K H Chow; Victor F Froelicher; Ian S Rogers; David P Lee; William F Fearon; Alan C Yeung; Marcia L Stefanick; Jennifer A Tremmel
Journal:  Int J Cardiol       Date:  2018-10-23       Impact factor: 4.039

8.  IL-6-targeted ultrasmall superparamagnetic iron oxide nanoparticles for optimized MRI detection of atherosclerotic vulnerable plaques in rabbits.

Authors:  Huaqiang Mo; Chenxing Fu; Zhiye Wu; Peng Liu; Zhibo Wen; Qingqing Hong; Yanbin Cai; Gongxin Li
Journal:  RSC Adv       Date:  2020-04-17       Impact factor: 3.361

9.  2-Dimensional Speckle Tracking Echocardiography predicts severe coronary artery disease in women with normal left ventricular function: a case-control study.

Authors:  Ryan T Hubbard; Maria C Arciniegas Calle; Sergio Barros-Gomes; Joyce A Kukuzke; Patricia A Pellikka; Rajiv Gulati; Hector R Villarraga
Journal:  BMC Cardiovasc Disord       Date:  2017-08-24       Impact factor: 2.298

10.  Prognosis of Coronary Atherosclerotic Burden in Non-Ischemic Dilated Cardiomyopathies.

Authors:  Marjorie Canu; Léa Margerit; Ismail Mekhdoul; Alexis Broisat; Laurent Riou; Loïc Djaileb; Clémence Charlon; Adrien Jankowski; Michele Magnesa; Caroline Augier; Stéphanie Marlière; Muriel Salvat; Charlotte Casset; Marion Maurin; Carole Saunier; Daniel Fagret; Catherine Ghezzi; Gerald Vanzetto; Gilles Barone-Rochette
Journal:  J Clin Med       Date:  2021-05-18       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.